Generative Data Intelligence

Biogen, Genentech Head To June Trial Over MS Drug Royalties

Date:

Node: 4555964
By Dorothy Atkins ( April 15, 2025, 10:37 PM EDT) — A California federal judge on Tuesday denied Biogen’s bid for summary judgment in a high-stakes contract fight with Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, saying during a hearing that there’s a material dispute over the contract’s language and the case will be tried in June….